Sage Journals: Discover world-class research

Open access

Review article

First published 2020

Tuberculosis and targeted synthetic or biologic DMARDs,beyond tumor necrosis factor inhibitors

Gerasimos Evangelatos, Vasiliki Koulouri, Alexios Iliopoulos [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2026

Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset

Jiha Lee, Sofia Pedro, Sara H. Bares [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2023-12

Efficacy and Safety of Conventional Synthetic,Biologic and Targeted Synthetic DMARDs in RA-ILD: A Narrative Review

Richard Conway, Elena Nikiphorou

Indian Journal of Rheumatology

Open access

Research article

First published 2024

Switching related to inefficacy in biologics and targeted synthetic therapies for psoriatic arthritis: a comparative real-life study

Dalifer Freites-Nuñez, Leticia Leon, Esther Toledano [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2024

Monotherapy or combination therapy in PsA: current aspects

Elpida Skouvaklidou, Paraskevi Avgerou, Konstantinos D. Vassilakis [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Review article

First published 2018-8

Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis

Eric G. Boyce, Edward L. Rogan, Deepti Vyas [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2022

Incidence and factors related to SARS-CoV-2 infection in a cohort of patients with rheumatoid arthritis from a health service provider in Colombia during the COVID-19 pandemic

Luis Fernando Valladales-Restrepo, Manuel Enrique Machado-Duque, Andrés Gaviria-Mendoza [...]

Therapeutic Advances in Infectious Disease

Open access

Case report

First published 2020

Baricitinib exposure during pregnancy in rheumatoid arthritis

Giulia Costanzo, Davide Firinu, Francesca Losa [...]

Therapeutic Advances in Musculoskeletal Disease

Free access

Review article

First published 2016-10

Combination therapy with biologic agents in rheumatic diseases: current and future prospects

Kentaro Inui, Tatsuya Koike

Therapeutic Advances in Musculoskeletal Disease

Free access

Research article

First published 2016-10

Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach

Bridget Hodkinson, Kingsley Ross Magomero, Mohammed Tikly

Therapeutic Advances in Musculoskeletal Disease

Search results